Nevirapine Infant-Dose Pouch
Country of Operation
- Elizabeth Glaser Pediatric AIDS foundation (EGPAF)Not-for-profit
- Kenya Ministry of HealthGovernment
SummaryThe project in Kenya assists in providing single-dose nevirapine (NVP) which is a low-cost, efficacious therapy for prevention of mother-to-child transmission of HIV (PMTCT) prior to delivery.
The objective of the project is to evaluate the introduction and use of the NVP infant-dose pouch in a field setting in order to demonstrate use in health facilities providing PMTCT services, assess provider and end-user (HIV+ pregnant women) acceptability and evaluate ease of use.
Key program components
The program has provided 543 pouched doses of NVP syrup in 1-ml Exacta-Med® dispensers to HIV+ pregnant women in advance of giving birth. Most providers found it easy to use and felt there was an increase in the quality of services they provided as a result of using the pouch. 98% of HIV+ mothers interviewed reported liking the infant-dose pouch with 45% of them giving birth at home and 55% in the facility where they received the NVP and 100% of HIV+ mothers interviewed reported that their infant received the dose of NVP (either in a facility or at home).